Insider Transactions Reported by 21 Insiders of Xenon Pharmaceuticals Inc.

Symbol
XENE on Nasdaq
Location
Burnaby

Insiders trading volume in the past year

Xenon Pharmaceuticals Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Michael R. Hayden Director $3,178,448 03 Jun 2021
Ian Mortimer PRESIDENT & CEO, Director $1,741,173 -$21,298,056 -92% 12 Mar 2026
Frank A. Holler Director $1,426,644 27 May 2021
Gary Patou Director $1,168,899 05 Jun 2025
Michael M. Tarnow Director $767,729 18 May 2021
Mohammad Azab Director $731,116 19 Dec 2023
Andrea DiFabio Chief Legal Officer $403,197 -$230,814 -36% 12 Mar 2026
Christopher John Kenney Chief Medical Officer $390,385 -$244,427 -39% 12 Mar 2026
Sherrington Robin EVP, Strategy & Innovation $388,827 11 Mar 2024
Steven Gannon Director $217,657 -$91 -0.04% 05 Jun 2025
Simon N. Pimstone Director $59,100 02 Jun 2023
Sherry Aulin Chief Financial Officer $0 18 Dec 2024
Patrick Machado Director 05 Jun 2025
Elizabeth A. Garofalo Director 05 Jun 2025
Dawn Svoronos Director 05 Jun 2025
Thomas Patrick Kelly Chief Financial Officer 15 Oct 2025
Darren S. Cline Chief Commercial Officer 09 Jan 2026
Gillian M. Cannon. Director 05 Jun 2025
Justin D. Gover Director 05 Jun 2025
James R. Empfield EVP, Drug Discovery 11 Mar 2024
Christopher von Seggern Chief Commercial Officer 11 Mar 2024

Recent Insider Transactions by Companies or Individuals for Xenon Pharmaceuticals Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Christopher John Kenney XENE Common Shares Sale -16.6% $77,867 $55.22 -1,410 7,069 13 Mar 2026 Direct
Andrea DiFabio XENE Common Shares Sale -15.5% $74,112 $55.22 -1,342 7,301 13 Mar 2026 Direct
Ian Mortimer XENE Common Shares Sale -26.8% $403,584 $55.22 -7,308 19,923 13 Mar 2026 Direct
Christopher John Kenney XENE Common Shares Options Exercise 79.3% 3,750 8,479 12 Mar 2026 Direct
Christopher John Kenney XENE Restricted Share Units Options Exercise -25% -3,750 11,250 12 Mar 2026 Direct
Andrea DiFabio XENE Common Shares Options Exercise 76.6% 3,750 8,643 12 Mar 2026 Direct
Andrea DiFabio XENE Restricted Share Units Options Exercise -25% -3,750 11,250 12 Mar 2026 Direct
Ian Mortimer XENE Common Shares Options Exercise 84.9% 12,500 27,231 12 Mar 2026 Direct
Ian Mortimer XENE Restricted Share Units Options Exercise -25% -12,500 37,500 12 Mar 2026 Direct
Andrea DiFabio XENE Common Shares Sale -34.8% $156,702 $60.11 -2,607 4,893 10 Mar 2026 Direct
Christopher John Kenney XENE Common Shares Sale -37% $166,559 $60.11 -2,771 4,729 10 Mar 2026 Direct
Ian Mortimer XENE Common Shares Sale -43.3% $677,357 $60.11 -11,269 14,731 10 Mar 2026 Direct
Andrea DiFabio XENE Common Shares Options Exercise 7,500 7,500 09 Mar 2026 Direct
Andrea DiFabio XENE Performance Share Units Options Exercise -100% -7,500 0 09 Mar 2026 Direct
Andrea DiFabio XENE Performance Share Units Award 7,500 7,500 09 Mar 2026 Direct
Christopher John Kenney XENE Common Shares Options Exercise 7,500 7,500 09 Mar 2026 Direct
Christopher John Kenney XENE Performance Share Units Options Exercise -100% -7,500 0 09 Mar 2026 Direct
Christopher John Kenney XENE Performance Share Units Award 7,500 7,500 09 Mar 2026 Direct
Ian Mortimer XENE Common Shares Sale -97.8% $16,289,142 $60.33 -270,000 6,000 09 Mar 2026 Direct
Ian Mortimer XENE Common Shares Options Exercise 290,000 111,000 09 Mar 2026 Direct
Ian Mortimer XENE Performance Share Units Options Exercise -100% -20,000 0 09 Mar 2026 Direct
Ian Mortimer XENE Performance Share Units Award 20,000 20,000 09 Mar 2026 Direct
Ian Mortimer XENE Stock Option Options Exercise -100% -270,000 0 09 Mar 2026 Direct
Christopher John Kenney XENE Restricted Share Units Award 20,000 20,000 09 Jan 2026 Direct
Christopher John Kenney XENE Share Option (Right to Buy) Award 100,000 100,000 09 Jan 2026 Direct
Darren S. Cline XENE Restricted Share Units Award 20,000 20,000 09 Jan 2026 Direct
Darren S. Cline XENE Share Option (Right to Buy) Award 40,000 40,000 09 Jan 2026 Direct
Andrea DiFabio XENE Restricted Share Units Award 15,000 15,000 09 Jan 2026 Direct
Andrea DiFabio XENE Share Option (Right to Buy) Award 80,000 80,000 09 Jan 2026 Direct
Ian Mortimer XENE Restricted Share Units Award 65,000 65,000 09 Jan 2026 Direct
Ian Mortimer XENE Share Option (Right to Buy) Award 350,000 350,000 09 Jan 2026 Direct
Ian Mortimer XENE Common Shares Sale -87% $1,777,093 $44.43 -40,000 6,000 02 Jan 2026 Direct
Ian Mortimer XENE Common Shares Options Exercise 666.7% 40,000 46,000 02 Jan 2026 Direct
Ian Mortimer XENE Stock Option (Right to Buy) Options Exercise -100% -40,000 0 02 Jan 2026 Direct
Ian Mortimer XENE Common Shares Sale -64.4% $495,207 $45.73 -10,830 6,000 08 Dec 2025 Direct
Ian Mortimer XENE Common Shares Sale -46.1% $647,306 $45.03 -14,375 16,830 05 Dec 2025 Direct
Ian Mortimer XENE Common Shares Sale -0.31% $4,366 $45.01 -97 31,205 28 Nov 2025 Direct
Thomas Patrick Kelly XENE Restricted Share Units Award 30,000 30,000 15 Oct 2025 Direct
Thomas Patrick Kelly XENE Share Option (Right to Buy) Award 225,000 225,000 15 Oct 2025 Direct
Ian Mortimer XENE Common Shares Sale -44.4% $1,004,000 $40.16 -25,000 31,302 01 Oct 2025 Direct
Ian Mortimer XENE Common Shares Options Exercise 79.9% 25,000 56,302 01 Oct 2025 Direct
Ian Mortimer XENE Stock Option (Right to Buy) Options Exercise -100% -25,000 0 01 Oct 2025 Direct
Darren S. Cline XENE Share Option (Right to Buy) Award 185,800 185,800 23 Jun 2025 Direct
Gary Patou XENE Restricted Share Units Award 2,645 2,645 05 Jun 2025 Direct
Gary Patou XENE Share Option (Right to Buy) Award 17,012 17,012 05 Jun 2025 Direct
Patrick Machado XENE Restricted Share Units Award 2,645 2,645 05 Jun 2025 Direct
Patrick Machado XENE Share Option (Right to Buy) Award 17,012 17,012 05 Jun 2025 Direct
Justin D. Gover XENE Restricted Share Units Award 2,645 2,645 05 Jun 2025 Direct
Justin D. Gover XENE Share Option (Right to Buy) Award 17,012 17,012 05 Jun 2025 Direct
Elizabeth A. Garofalo XENE Restricted Share Units Award 2,645 2,645 05 Jun 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.